# ArrayHope

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arrayhope

- Industry: Biotechnology
- Headquarters: Nanjing, China
- Latest round: Angel (Jul 1, 2022)
- Investors on record: 1

## About

Founded in 2021 and based in Nanjing, China, ArrayHope is a biotech company that focuses on developing proteomics research platform. In September 2024, the firm closed a strategic investment. As of September 2024, the company has collaborated with Johns Hopkins CDI LAB and top clinical centers in the country. In May 2025, ArrayHope raised over CNY 10 million of Series A.The company's main product is a proteomics research platform. The proteomics research platform provides research and development services for disease autoantibody diagnostic products. The company also focuses on the research, development, registration and commercialization of innovative IVD testing products. The company’s revenue is generated by providing a proteomics research platform. The company will use the funding for commercial team building and accelerating the development of lung cancer pipeline products.

## Funding rounds

- Angel, Jul 1, 2022 — Xingang East Capital

## Investors

- Xingang East Capital (https://capitalatlas.ai/funds/xingang-east-capital) — Angel